Previous
Next

Country/Region

March 20, 2017

Nicholas Gildersleeve is a Canadian from Frelighsburg, Quebec, who until recently served as Doctors Without Borders/Médecins Sans Frontières (MSF)’s head of mission in Bolivia — a country with the world’s highest incidence of Chagas, which is endemic in 60 per cent of its territory. The disease, which is found almost exclusively in Latin America and is transmitted by triatomine insects (also known as “kissing bugs”), is mostly asymptomatic for the first years of infection, but will often eventually result in debilitating complications that can shorten life expectancy by an average of 10 years. Heart complications are the most common cause of death in infected adults.

April 14, 2015

Médecins Sans Frontières/Doctors Without Borders (MSF) is launching a new project to ensure that people can be diagnosed and treated for Chagas disease in the town of Monteagudo, in the Chuquisaca department of southern Bolivia. In partnership with local healthcare institutions, the organization will develop a comprehensive care model for primary and secondary care that will be integrated into the existing healthcare system.

October 24, 2014

Following a high level meeting on access and funding for Ebola vaccines convened yesterday by World Health Organization (WHO), Médecins Sans Frontières/Doctors Without Borders (MSF) has urged that plans to get forthcoming Ebola vaccines and treatments to frontline workers must be rapidly implemented. Significant investment and incentives are needed now to accelerate these steps.

The medical humanitarian organization Médecins Sans Frontières (MSF) is shocked by the judgment rendered by Switzerland's highest judicial body, the Federal Tribunal. Following four years of proceedings, and in spite of two previous rulings in favour of MSF, the Federal Tribunal partly ruled in favour of the Dutch state by ruling that the financial burden should be shared between the two parties. This decision sets a grave precedent for independent humanitarian action in zones of conflict.

The Executive Board of UNITAID, the international health financing agency, will meet Dec. 14-15 in Geneva to decide on the future direction of the Patent Pool for AIDS medicines. International medical humanitarian organization Médecins Sans Frontières (MSF) is concerned that a number of pharmaceutical companies are seeking to exclude developing countries categorized as ‘middle-income’ from benefiting from medicines made under licence from the Pool.  If these companies are successful, people living with HIV/AIDS will be made to pay the price.

In a decisive step to improve access to medicines in the developing world, the Executive Board of UNITAID, the international health financing agency, has given the green light for a patent pool for HIV/AIDS medicines to open for business. “Although these are early days, the patent pool could become a mechanism that systematically offers licenses to generic manufacturers, reducing prices and facilitating the combination of drugs from different makers into fixed-dose or one pill combinations,” said Dr.